Remove Digital Health Remove Drug Development Remove Leadership
article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

23andMe announces major Workforce Reduction amid Financial Struggles

Digital Health Global

23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research. While promising, drug development requires significant time and investment, delaying any financial returns and impacting the company’s short-term revenue.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Regulatory Landscape: Changes in healthcare regulations and policies.

article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Subscribe Today!

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

The increasing importance of digital health, coupled with abundant capital and supportive regulatory environments, is likely to drive continued M&A activity and higher valuations. Regulatory Environment: Favourable regulatory policies and increased government support for digital health initiatives are fostering innovation.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

Here are some key trends and developments to watch: Key Trends: Technological Advancements: New technologies are revolutionizing wound care, including advanced wound dressings, bioengineered skin substitutes, and innovative wound management devices. This shift towards digitalisation is improving patient outcomes and reducing healthcare costs.